In addition to the two conventional screening targets for hypoglycemic activity mentioned above, protein tyrosine phosphatase 1B (PTP1B) is currently one of the most promising targets for the treatment of type 2 diabetes (T2D). The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.